LORLATINIB vs LOVASTATIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LORLATINIB vs LOVASTATIN: Safety Overview
| Metric | LORLATINIB | LOVASTATIN |
|---|---|---|
| Total FAERS Reports | 5,508 | 1,387 |
| Deaths Reported | 1,542 | 204 |
| Death Rate | 28.0% | 14.7% |
| Hospitalizations | 1,232 | 287 |
| Average Patient Age | 56.5 yrs | 60.2 yrs |
| % Female Patients | 54.0% | 55.9% |
| FDA Approval Date | Nov 2, 2018 | Apr 14, 2006 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Preferred Pharmaceuticals, Inc. |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Discontinued |